These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1154 related items for PubMed ID: 21518972
21. Geographic differences and the role of cagA gene in gastroduodenal diseases associated with Helicobacter pylori infection. Valmaseda Pérez T, Gisbert JP, Pajares García JM. Rev Esp Enferm Dig; 2001 Jul; 93(7):471-80. PubMed ID: 11685943 [Abstract] [Full Text] [Related]
23. Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization. Gottwein JM, Blanchard TG, Targoni OS, Eisenberg JC, Zagorski BM, Redline RW, Nedrud JG, Tary-Lehmann M, Lehmann PV, Czinn SJ. J Infect Dis; 2001 Aug 01; 184(3):308-14. PubMed ID: 11443556 [Abstract] [Full Text] [Related]
24. Evaluation of a new tumor necrosis factor-alpha-inducing membrane protein of Helicobacter pylori as a prophylactic vaccine antigen. Inoue K, Shiota S, Yamada K, Gotoh K, Suganuma M, Fujioka T, Ahmed K, Iha H, Nishizono A. Helicobacter; 2009 Oct 01; 14(5):135-43. PubMed ID: 19751439 [Abstract] [Full Text] [Related]
25. Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Prinz C, Schöniger M, Rad R, Becker I, Keiditsch E, Wagenpfeil S, Classen M, Rösch T, Schepp W, Gerhard M. Cancer Res; 2001 Mar 01; 61(5):1903-9. PubMed ID: 11280745 [Abstract] [Full Text] [Related]
26. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer. Klaamas K, Kurtenkov O, von Mensdorff-Pouilly S, Shljapnikova L, Miljukhina L, Brjalin V, Lipping A. Immunol Invest; 2007 Mar 01; 36(4):371-86. PubMed ID: 17691020 [Abstract] [Full Text] [Related]
27. Helicobacter pylori immunology and vaccines. Vorobjova T, Watanabe T, Chiba T. Helicobacter; 2008 Oct 01; 13 Suppl 1():18-22. PubMed ID: 18783517 [Abstract] [Full Text] [Related]
28. Helicobacter pylori-host cell interactions mediated by type IV secretion. Bourzac KM, Guillemin K. Cell Microbiol; 2005 Jul 01; 7(7):911-9. PubMed ID: 15953024 [Abstract] [Full Text] [Related]
29. Helicobacter pylori and gastric cancer: what can be learned by studying the response of gastric epithelial cells to the infection? Mueller A, Falkow S, Amieva MR. Cancer Epidemiol Biomarkers Prev; 2005 Aug 01; 14(8):1859-64. PubMed ID: 16103426 [Abstract] [Full Text] [Related]
30. Helicobacter pylori lipopolysaccharide promotes a Th1 type immune response in immunized mice. Taylor JM, Ziman ME, Huff JL, Moroski NM, Vajdy M, Solnick JV. Vaccine; 2006 Jun 05; 24(23):4987-94. PubMed ID: 16621176 [Abstract] [Full Text] [Related]
31. Potential role of CagA in the inhibition of T cell reactivity in Helicobacter pylori infections. Paziak-Domańska B, Chmiela M, Jarosińska A, Rudnicka W. Cell Immunol; 2000 Jun 15; 202(2):136-9. PubMed ID: 10896773 [Abstract] [Full Text] [Related]
32. TLR-2-activated B cells suppress Helicobacter-induced preneoplastic gastric immunopathology by inducing T regulatory-1 cells. Sayi A, Kohler E, Toller IM, Flavell RA, Müller W, Roers A, Müller A. J Immunol; 2011 Jan 15; 186(2):878-90. PubMed ID: 21149607 [Abstract] [Full Text] [Related]
33. Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers: a phase I study. Malfertheiner P, Schultze V, Rosenkranz B, Kaufmann SH, Ulrichs T, Novicki D, Norelli F, Contorni M, Peppoloni S, Berti D, Tornese D, Ganju J, Palla E, Rappuoli R, Scharschmidt BF, Del Giudice G. Gastroenterology; 2008 Sep 15; 135(3):787-95. PubMed ID: 18619971 [Abstract] [Full Text] [Related]
34. The development of therapeutic and preventive vaccines for gastric cancer and Helicobacter pylori. Chui SY, Clay TM, Lyerly HK, Morse MA. Cancer Epidemiol Biomarkers Prev; 2005 Aug 15; 14(8):1883-9. PubMed ID: 16103431 [Abstract] [Full Text] [Related]
35. The design of vaccines against Helicobacter pylori and their development. Del Giudice G, Covacci A, Telford JL, Montecucco C, Rappuoli R. Annu Rev Immunol; 2001 Aug 15; 19():523-63. PubMed ID: 11244046 [Abstract] [Full Text] [Related]
36. Increase of antigen-presenting cells in the gastric mucosa of Helicobacter pylori-infected children. Krauss-Etschmann S, Gruber R, Plikat K, Antoni I, Demmelmair H, Reinhardt D, Koletzko S. Helicobacter; 2005 Jun 15; 10(3):214-22. PubMed ID: 15904479 [Abstract] [Full Text] [Related]
37. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies. Camorlinga-Ponce M, Flores-Luna L, Lazcano-Ponce E, Herrero R, Bernal-Sahagún F, Abdo-Francis JM, Aguirre-García J, Muñoz N, Torres J. Cancer Epidemiol Biomarkers Prev; 2008 Sep 15; 17(9):2498-504. PubMed ID: 18768521 [Abstract] [Full Text] [Related]
38. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo. Rad R, Brenner L, Bauer S, Schwendy S, Layland L, da Costa CP, Reindl W, Dossumbekova A, Friedrich M, Saur D, Wagner H, Schmid RM, Prinz C. Gastroenterology; 2006 Aug 15; 131(2):525-37. PubMed ID: 16890606 [Abstract] [Full Text] [Related]
39. Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia. Arnold IC, Lee JY, Amieva MR, Roers A, Flavell RA, Sparwasser T, Müller A. Gastroenterology; 2011 Jan 15; 140(1):199-209. PubMed ID: 20600031 [Abstract] [Full Text] [Related]
40. Orchestration of aberrant epithelial signaling by Helicobacter pylori CagA. Peek RM. Sci STKE; 2005 Mar 29; 2005(277):pe14. PubMed ID: 15798102 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]